DOCSLIB.ORG

Everbright Securities Company Limited 光大證券股份有限公司 (A Joint Stock Company Incorporated in the People’S Republic of China with Limited Liability) (Stock Code: 6178)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Everbright Securities Company Limited 光大證券股份有限公司 (A Joint Stock Company Incorporated in the People’S Republic of China with Limited Liability) (Stock Code: 6178) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Everbright Securities Company Limited 光大證券股份有限公司 (A joint stock company incorporated in the People’s Republic of China with limited liability) (Stock Code: 6178) ANNOUNCEMENT OF annual RESULTS FOR THE YEAR ENDED DECEMBER 31, 2016 The board of directors (the “Board”) of Everbright Securities Company Limited (the “Company”) hereby announces the audited annual results of the Company and its subsidiaries (the “Group”) for the year ended December 31, 2016. This announcement, containing the full text of the 2016 annual report of the Company, complies with the relevant requirements of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited in relation to information to accompany preliminary announcement of annual results. The Group’s final results for the year ended December 31, 2016 have been reviewed by the audit committee of the Company. This results announcement will be published on the website of The Stock Exchange of Hong Kong Limited (www.hkexnews.hk) and the Company’s website (www.ebscn.com). The Company’s 2016 annual report will be dispatched to the holders of H shares of the Company and published on the websites of The Stock Exchange of Hong Kong Limited and the Company in due course. By order of the Board Everbright Securities Company Limited Xue Feng Chairman, President Shanghai, the PRC March 29, 2017 As at the date of this announcement, the Board comprises Mr. Gao Yunlong (Non-executive Director), Mr. Ge Haijiao (Non-executive Director), Mr. Xue Feng (Chairman, Executive Director, President), Mr. Yin Lianchen (Non-executive Director), Mr. Chan Ming Kin (Non-executive Director), Mr. Yang Guoping (Non-executive Director), Mr. Zhu Ning (Independent Non-executive Director), Mr. Xu Jingchang (Independent Non-executive Director), Mr. Xiong Yan (Independent Non-executive Director), Mr. Li Zheping (Independent Non-executive Director) and Mr. Au Sing Kun (Independent Non-executive Director). Everbright Securities Company Limited / Annual Report 2016 CONTENTS Section I Definitions and Warning of Material Risks 3 Section II Company Profile and Key Financial Indicators 7 Section III Summary on the Business of the Company 19 Section IV Report of the Board 23 Section V Significant Events 47 Section VI Changes in Ordinary Shares and Particulars about Shareholders 62 Section VII Particulars about Directors, Supervisors, Senior Management and Staff 72 Section VIII Corporate Governance 90 Section IX Relevant Information on Corporate Bonds 121 Section X Financial Report 125 2 Everbright Securities Company Limited IMPORTANT Notice I. The Board, the Supervisory Committee, Directors, Supervisors and senior management of the Company warrant that this annual report is true, accurate and complete and does not contain any false records, misleading statements or material omission and jointly and severally take full legal responsibility as to the contents herein. II. This report was reviewed and passed at the 28th meeting of the fourth session of the Board of the Company. The number of Directors that should attend the Board meeting was 11 and the number of Directors having voted at the Board meeting was 11. Mr. Xu Jingchang and Mr. Zhu Ning were authorized by Mr. Yang Guoping and Mr. Li Zheping to exercise their rights of voting, respectively. None of the Directors or Supervisors has made any objection to this report. III. Unless otherwise specified, the financial data disclosed in this report are prepared in accordance with the International Financial Reporting Standards and have been audited by KPMG, whom then issued a standard unqualified audit report thereon. Unless otherwise stated, the financial data set out in this report are denominated in RMB. IV. Mr. Xue Feng, the person-in-charge of the Company, Mr. Wang Yong, the person-in-charge of accounting affairs, and Mr. He Mannian, the head of accounting department, declare that they warrant the truthfulness, accuracy and completeness of the financial statements contained in this annual report. V. The profit distribution proposal or proposal on transfer of capital reserve into share capital reviewed by the Board for the Reporting Period is as follows: On the basis of a total share capital of 4,610,787,639 A Shares and H Shares in issue as of December 31, 2016, cash dividend of RMB2.00 per 10 shares (inclusive of tax) will be distributed to all holders of A Shares and H Shares, with total cash dividend amounting to RMB922,157,527.80. The above distribution proposal will be proposed at the general meeting of the Company for consideration and is subject to the approval by the Company’s shareholders at the general meeting before the execution thereof. VI. Forward-looking statements included in this report, including future plans and development strategies, do not constitute actual commitment of the Company to investors. Investors should be reminded of the risks of investment. VII. There was no appropriation of funds on a non-recurring basis by the Company's controlling shareholders or their related parties during the Reporting Period. VIII. The Company has not provided any external guarantees in violation of the prescribed decision-making procedures during the Reporting Period. IX. The Company prepared this annual report in both English and Chinese versions. In the event of any discrepancies in interpretation between the English version and Chinese version, the Chinese version shall prevail. Annual Report 2016 3 SECTION I DEFINITIONS AND WARNING OF MATERIAL RISKS I. Definitions In this annual report, unless the context otherwise requires, the following terms and expressions shall have the meanings set forth below: Company, our Company or Everbright Securities Company Limited (光大證券股份有限公司) Everbright Securities Everbright Group China Everbright Group Ltd. (中國光大集團股份公司), the largest shareholder of the Company Everbright Limited China Everbright Limited (中國光大控股有限公司), the second largest shareholder of the Company Everbright Capital Everbright Capital Investment Co., Ltd. (光大資本投資有限公司), a wholly-owned subsidiary of the Company Everbright Fortune Everbright Fortune Investment Co., Ltd. (光大富尊投資有限公司), a wholly-owned subsidiary of the Company Everbright Futures Everbright Futures Co., Ltd. (光大期貨有限公司), a wholly-owned subsidiary of the Company Everbright Asset Management Shanghai Everbright Securities Asset Management Co., Ltd. (上海光大 證券資產管理有限公司), a wholly-owned subsidiary of the Company EBSHK Everbright Securities Financial Holdings Limited (光大證券金融控股有限 公司), a wholly-owned subsidiary of the Company Everbright Pramerica Everbright Pramerica Fund Management Co., Ltd. (光大保德信基金管理 有限公司), a controlling subsidiary of the Company Everbright Leasing Everbright Fortune International Leasing Co., Ltd. (光大幸福國際租賃有 限公司), a subsidiary of the Company Everbright Easecreate Everbright Easecreate Network Technology Co., Ltd. (光大易創網絡科技 股份有限公司) Everbright Yunfu Everbright Yunfu Internet Co., Ltd. (光大雲付互聯網股份有限公司) ESIL Everbright Securities (International) Limited (光大證券（國際）有限公司), a wholly-owned subsidiary of EBSHK SHKFGL Sun Hung Kai Financial Group Limited (新鴻基金融集團有限公司), whose equity interest is held 70% and 30% by EBSHK and Sun Hung Kai & Co. Limited, respectively 4 Everbright Securities Company Limited SECTION I DEFINITIONS AND WARNING OF MATERIAL RISKS Dacheng Fund Dacheng Fund Management Co., Ltd. (大成基金管理有限公司), a joint venture of the Company Reporting Period the year of 2016 (January 1, 2016 to December 31, 2016) Directors the directors of the Company Board, Board of Directors The board of Directors of the Company Supervisors the supervisors of the Company Supervisory Committee The supervisory committee of the Company NEEQ National Equities Exchange and Quotations (全國中小企業股份轉讓系統) MOF Ministry of Finance of the PRC (中華人民共和國財政部) Huijin Central Huijin Investment Ltd. (中央匯金投資有限責任公司) PBOC People’s Bank of China, the central bank of the PRC SAFE State Administration of Foreign Exchange of the PRC (中華人民共和國 國家外匯管理局) PB Prime brokerage PPP Public-private Partnership FICC Fixed-income, Currencies and Commodities QFII Qualified foreign institutional investor securitization, ABS financing through issuance of tradable securities backed by specific asset portfolios or cash flows margin financing and provision of collateral by investors to securities firms to borrow funds for securities lending securities purchases (margin financing) or to borrow and sell securities (securities lending) maintenance margin ratio the ratio of all the collateral from the clients of margin financing and securities lending business (including the amount of cash and the market value of securities held in margin securities account) to the margin balance of clients (the sum of the amount of margin loans purchased, the latest market value of securities lent and any accrued interest and fees) Annual Report 2016 5 SECTION I DEFINITIONS AND WARNING OF MATERIAL RISKS collateralized stock repurchase a transaction in which a qualified borrower pledges his shares or other securities held as collaterals to obtain financing funds from a qualified lender, and agrees to repay the funds on a future date to release the pledge security transactions with a transaction in which a qualified
Load more

Recommended publications
  • Board of Director's Operating Report for Financial Statement At
    Board of Director’s Operating Report for Financial Statement at December 31, 2008 126 Financial Statement 2008 - Management Report Shareholders, The 2008 financial statements, prepared on the basis of IAS/IFRS international accounting standards, report on your company’s twenty-eighth year in business, closing with a profit of 21.2 million euro (+ 18.7% over 2007), after payment of 7.8 million Euro in taxes. R.O.E. was 27.40%, significantly higher than in 2007 (24.05%). On the topic of competitive positioning, note that in 2008 the company ranked fifth in its sector in terms of outstanding credit, with a market share of 6.0%, and fourth in terms of advances and payments made, with a market share of 6.7% (source: Assifact). The annual profit, though it did reflect the effects of certain non-recurrent events, is definitely noteworthy in terms of management of regular operations. In the year 2008 profit margins reflected replacement of about 3.0 million Euro in gains from purchases of credit not at face value (now a residual activity), which were entered under “Other operating income” in 2007, with profit margins from characteristic operations, marking the completion of the commercial strategy undertaken since 2006 aiming to improve performance on the working capital market for customer companies, the number of which has definitely grown (+ 43% active transferring customers). The Operating Margin was 49.2 million euro, up 12.4% over 2007. This performance is primarily attributable to Interest Margin dynamics, which have settled at 34.0 million euro (+26.4% over 2007), while Net Commissions were worth 15.2 million euro (-10.0 % since 2007).
    [Show full text]
  • LEAGUE TABLES Q1 2020 Preliminary As of 25 March 2020 Q1 2020 PRELIMINARY AS of 25 MARCH 2020
    GLOBAL EQUITY CAPITAL MARKETS LEAGUE TABLES Q1 2020 Preliminary As of 25 March 2020 Q1 2020 PRELIMINARY AS OF 25 MARCH 2020 MANAGER RANKINGS GLOBAL EQUITY, EQUITY LINKED & RIGHTS CONTENTS Bloomberg’s global equity offerings database consists of nearly 87,000 deals (with approximately 43,000 IPOs and over 43,000 additional offerings), and coverage of more than 1. Global market review 500 financial advisors and 500 legal advisors. 2. US market review LEAG<GO> for a full range of league tables 3. Canada market review IPO<GO> for Bloomberg’s equity offerings product 4. Latin America market review Due to the dynamic nature of the Professional Service product, league table rankings may vary between 5. EMEA market review this release and data found on the Bloomberg Professional Service. 6. Asia market review 7. Table criteria DATA SUBMISSIONS AND QUERIES Contact Phone Email North America Larisa Bykova +1 646 324 2355 [email protected] EMEA Dimitri Quemard +44 20 3525 0253 [email protected] Asia-Pacific Zhen Hao Toh +65 6499 2931 [email protected] © 2020 Bloomberg Finance L.P. All rights reserved. Bloomberg Preliminary Global Equity | Q1 2020 Global Equity, Equity Linked & Rights: Industry Breakdown Global Equity Review 8% Financials 22% Q1 2020 credited Global Equity, Equity Linked & Rights volume decreased 3.11% to USD 128.6 Bln while deal count 5% 22% Health Care 18% decreased 8.94% to 906 offerings year-on-year. Global Equity IPO volume increased 73.37% year-on-year to USD 32.2 Bln 6% Consumer Discretionary 16% while the deal count decreased 0.40% to 247.
    [Show full text]
  • PEI 300 Guess Who’S Back on Top?
    Issue 165 | May 2018 | privateequityinternational.com PEI 300 Guess who’s back on top? THE ORACLE SPEAKS David Rubenstein on the future of private capital SECONDARIES ROUNDTABLE Keeping LPs front and centre WHY PRIVATE EQUITY? The asset allocation special PLUS: the PEI Q1 Fundraising Report; IRRs vs money multiples; introducing the CEPRES model portfolio; Texas TRS goes Canadian; inside the PE retail blowouts; and much more… Equistone announced the successful final We are one of close of Fund VI at its €2.8bn hard cap in March 2018. Europe’s most Equistone has made three investments for Fund VI and will continue to source deals active mid-market and build value with management teams across our target markets. investors. www.equistonepe.com Evercore acted as the exclusive global placement agent for Equistone Partners Europe Fund VI. © EQUISTONE PARTNERS EUROPE LIMITED Authorised and regulated by The Financial Conduct Authority. PE International Ad May 2018.indd 1 18/04/2018 15:18 Riding high historically it’s been successful, but it needs to ISOBEL ISSN 1474–8800 | ISSUE 165 | MARKHAM work hard to avoid becoming a victim of that MAY 2018 EDITOR'S success. The signs are already there that this LETTER is starting to happen. Senior Editor, Private Equity Toby Mitchenall Tel: +44 207 566 5447 Sandra Robertson, chief investment officer [email protected] and chief executive of the UK’s £3 billion ($4.3 Americas Editor, Private Equity Marine Cole billion; €3.4 billion) Oxford University Endow- Tel: +1 212 633 1455 [email protected] ment
    [Show full text]
  • Schedule of Investments (Unaudited) Ishares MSCI Total International Index Fund (Percentages Shown Are Based on Net Assets) September 30, 2020
    Schedule of Investments (unaudited) iShares MSCI Total International Index Fund (Percentages shown are based on Net Assets) September 30, 2020 Mutual Fund Value Total International ex U.S. Index Master Portfolio of Master Investment Portfolio $ 1,034,086,323 Total Investments — 100.4% (Cost: $929,170,670) 1,034,086,323 Liabilities in Excess of Other Assets — (0.4)% (3,643,126) Net Assets — 100.0% $ 1,030,443,197 iShares MSCI Total International Index Fund (the “Fund”) seeks to achieve its investment objective by investing all of its assets in International Tilts Master Portfolio (the “Master Portfolio”), which has the same investment objective and strategies as the Fund. As of September 30, 2020, the value of the investment and the percentage owned by the Fund of the Master Portfolio was $1,034,086,323 and 99.9%, respectively. The Fund records its investment in the Master Portfolio at fair value. The Fund’s investment in the Master Portfolio is valued pursuant to the pricing policies approved by the Board of Directors of the Master Portfolio. Fair Value Hierarchy as of Period End Various inputs are used in determining the fair value of financial instruments. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial reporting purposes as follows: • Level 1 – Unadjusted price quotations in active markets/exchanges for identical assets or liabilities that the Fund has the ability to access • Level 2 – Other observable inputs (including, but not limited to, quoted prices
    [Show full text]
  • Interim Report for the Six Months Ended 30 June 2008
    China Everbright Limited 中國光大控股有限公司 (Stock Code: 165) Interim Report For the six months ended 30 June 2008 簡單成就價值 Making Wealth Simple BOARD OF DIRECTORS Tang Shuangning Chairman Zang Qiutao Deputy Chairman Chen Shuang Chief Executive Officer Tang Chi Chun, Richard Chief Financial Officer + Wang Weimin * Ng Ming Wah, Charles * Seto Gin Chung, John * Lin Zhijun + Non-executive Director * Independent Non-executive Directors COMPANY SECRETARY LEGAL ADVISOR Chan Ming Kin Messrs. Wilkinson & Grist REGISTERED OFFICE SHARE REGISTRARS Room 4001, 40th Floor Tricor Secretaries Limited Far East Finance Centre 26th Floor, Tesbury Centre 16 Harcourt Road 28 Queen’s Road East Hong Kong Wanchai Hong Kong PRINCIPAL BANKERS AUDITORS Standard Chartered Bank (Hong Kong) Limited KPMG Bank of Communications Company, Limited Fubon Bank (Hong Kong) Limited Hang Seng Bank Limited WEBSITE ADDRESS http://www.everbright165.com.hk STOCK CODE: 165 China Everbright Limited Interim Report 2008 1 INTERIM RESULTS The Directors of China Everbright Limited (the “Company”) are pleased to announce the unaudited results of the Company and its subsidiaries (the “Group”) for the six months ended 30 June 2008. The interim financial report is prepared on a basis consistent with the accounting policies and methods adopted in the 2007 audited accounts. The interim financial report is unaudited, but has been reviewed by KPMG, in accordance with Hong Kong Standard on Review Engagements 2410, “Review of interim financial information performed by the independent auditor of the entity” issued by the Hong Kong Institute of Certified Public Accountants, KPMG’s review report to the Board of Directors of the Company is included on page 23.
    [Show full text]
  • Life Sciences and Healthcare
    Life Sciences and Healthcare Beijing Guangzhou Hong Kong Shanghai Shenzhen 27/F, North Tower 17/F, International Finance 26/F, One Exchange Square 24/F, HKRI Centre Two, 17/F, Tower One, Kerry Plaza Beijing Kerry Centre Place, 8 Huaxia Road, 8 Connaught Place, Central HKRI Taikoo Hui 1 Zhong Xin Si Road 1 Guanghua Road Zhujiang New Town Hong Kong 288 Shi Men Yi Road Futian District Chaoyang District Guangzhou 510623, China Shanghai 200041, China Shenzhen 518048, China Beijing 100020, China Tel: +86 10 5769 5600 Tel: +86 20 3225 3888 Tel: +852 3976 8888 Tel: +86 21 2208 1166 Tel: +86 755 8159 3999 Fax:+86 10 5769 5788 Fax:+86 20 3225 3899 Fax:+852 2110 4285 Fax:+86 21 5298 5599 Fax:+86 755 8159 3900 www.fangdalaw.com Life Sciences and Healthcare Life Sciences and Healthcare 01 The Preeminent China-based International Law Firm Founded in 1993 and one of the most prestigious law firms Our service to clients is premised on the dual foundations in the region, Fangda Partners has over 700 lawyers. We of strong local law capabilities and a global business outlook. serve a wide variety of major clients – including large MNCs, Our lawyers are qualified in many jurisdictions, including global financial institutions, leading Chinese enterprises the People's Republic of China, Hong Kong SAR, England and fast-growing Hi-tech companies – on an extensive range and Wales, the United States, Singapore and Australia. of commercial matters through our network offices in Beijing, Guangzhou, Hong Kong, Shanghai and Shenzhen, Our understanding of the laws and processes in major offering PRC law and Hong Kong law.
    [Show full text]
  • Everbright Investment Conference 2014 Held in Xiamen
    Everbright Investment Conference 2014 held in Xiamen More than 350 investors and industry experts participate to discuss investment opportunities exhibited locally and abroad On 29-31 October 2014, China Everbright Limited (“Everbright”, stock code: 165.HK) held the Everbright Investment Conference 2014 in Xiamen to explore the current economic development trends in China as well as investment opportunities and challenges China faces in the asset management industry, attracting a total of more than 350 investors and industry experts to participate in it. “Venturing Beyond Your Horizon” was the theme for the Investment Conference. Industry experts congregated to discuss the in-depth development trend of China’s economy and the asset management industry as well as to provide a comprehensive analysis of where China is situated in the global asset management market and the challenges to overcome. They explored how China can advance in the international capital market as well as further grasp global investment opportunities and to discover how to attract overseas capital into the Chinese market to further spring the momentum of China’s economic development. The conference began with a welcome remarks and opening speech by Everbright’s Executive Director and CEO Mr. Chen Shuang, followed by a keynote speech by Deputy General Manager of China Everbright Group Limited and Deputy Chairman of the Board of Directors of China Everbright Limited Dr. Liu Jun, and The National Council for Social Security Fund’s Vice-Chairman, Mr. Wang Zhongmin, talking about financial crisis and risk management as well as the economic ecosystem of internet investment. Mr. Chen Shuang, together with Sequoia Capital China’s Founding Managing Partner, Mr.
    [Show full text]
  • League Tables
    GLOBAL EQUITY CAPITAL MARKET LEAGUE TABLES Q1 2016 Q1 2016 MANAGER RANKINGS GLOBAL EQUITY, EQUITY LINKED & RIGHTS CONTENTS Bloomberg’s global equity offerings database consists of nearly 87,000 deals (with approximately 43,000 IPOs and over 43,000 additional offerings), and coverage of more than 500 financial advisors 1. Global market review and 500 legal advisors. 2. US market review LEAG<GO> for a full range of league tables 3. Canada market review IPO<GO> for Bloomberg’s equity offerings product 4. Latin America market review 5. EMEA market review Due to the dynamic nature of the Professional Service product, league table rankings may vary between this release 6. Asia market review and data found on the Bloomberg Professional Service. 7. Table criteria DATA SUBMISSIONS AND QUERIES Contact Phone Email North America Elizabeth Entrup +1 646 324 4666 [email protected] Irina Arefyeva +1 646 324 4663 [email protected] EMEA Karan Aswani +44 20 3525 4331 [email protected] Asia Pacific Billy Sun +886 2 7719 1571 [email protected] © 2015 Bloomberg Finance L.P. All rights reserved. Global Equity, Equity Linked & Rights: Industry Breakdown Global Equity Review Technology 27% 11% Financials 18% Q1 2016 credited Global Equity, Equity Linked & Rights volume decreased 56.27% to USD 102.5 Bln while deal 5% 27% count decreased 42.90% to 627 offerings year-on-year. Global Equity IPO volume decreased 65.23% year-on- 6% Energy 16% year to USD 14.1 Bln while the deal count decreased 36.23% to 176. Global Equity Linked volume decreased Health Care 9% 41.99% year-on-year to USD 15.8 Bln over 61 deals.
    [Show full text]
  • Everbright Securities Company Limited 光大證券股份有限公司 (A Joint Stock Company Incorporated in the People’S Republic of China with Limited Liability) (Stock Code: 6178)
    Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Everbright Securities Company Limited 光大證券股份有限公司 (A joint stock company incorporated in the People’s Republic of China with limited liability) (Stock Code: 6178) ANNOUNCEMENT OF annual RESULTS FOR THE YEAR ENDED DECEMBER 31, 2018 The board of directors (the “Board”) of Everbright Securities Company Limited (the “Company”) hereby announces the audited annual results of the Company and its subsidiaries (the “Group”) for the year ended December 31, 2018. This announcement, containing the full text of the 2018 annual report of the Company, complies with the relevant requirements of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited in relation to information to accompany preliminary announcement of annual results. The Group’s final results for the year ended December 31, 2018 have been reviewed by the audit committee of the Company. This results announcement will be published on the website of The Stock Exchange of Hong Kong Limited (www.hkexnews.hk) and the Company’s website (www.ebscn.com). The Company’s 2018 annual report will be dispatched to the holders of H shares of the Company and published on the websites of The Stock Exchange of Hong Kong Limited and the Company in due course.
    [Show full text]
  • View Annual Report
    STEALTH BIOTHERAPEUTICS CORP FORM 20-F (Annual and Transition Report (foreign private issuer)) Filed 04/04/19 for the Period Ending 12/31/18 Telephone 617-600-6888 CIK 0001696396 Symbol MITO SIC Code 2834 - Pharmaceutical Preparations Industry Biotechnology & Medical Research Sector Healthcare Fiscal Year 12/31 http://www.edgar-online.com © Copyright 2020, EDGAR Online, a division of Donnelley Financial Solutions. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, a division of Donnelley Financial Solutions, Terms of Use. Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report Commission file number: 001-38810 STEALTH BIOTHERAPEUTICS CORP (Exact name of Registrant as specified in its charter) N/A (Translation of Registrant’s name into English) Cayman Islands (Jurisdiction of incorporation) Stealth BioTherapeutics Corp c/o Intertrust Corporate Services (Cayman) Limited 190 Elgin Avenue, George Town Grand Cayman KY1-9005 Cayman Islands (address of principal
    [Show full text]
  • Tingyi (322 HK) up MP OP Preview: 2Q17 Earnings Could Beat on Bottled Water and Expense Savings
    Last Close: HK$10.92 Upside: -18% Target Price: HK$9.00↑ Consumer Sector Tingyi (322 HK) UP MP OP Preview: 2Q17 earnings could beat on bottled water and expense savings Financial Highlights Y/E 31 Dec 2015 2016 2017E 2018E 2019E LT Revenue (US$m) 9,103 8,372 8,756 9,154 9,580 Neutral BUY YoY (%) -11.1 -8.0 4.6 4.5 4.7 EBIT margin 5.2 4.8 5.1 5.3 5.6 SELL BUY Net profit (US$m) 256 177 245 280 332 Diluted EPS (US$) 0.046 0.032 0.044 0.050 0.059 YoY (%) -35.9 -30.9 38.5 14.1 18.7 P/E (x) 30.8 44.6 32.2 28.2 23.8 P/B (x) 2.0 2.3 2.2 2.0 1.9 Stock P/S (x) 0.9 0.9 0.9 0.9 0.8 Dividend yield (%) 1.6 1.1 1.6 1.8 2.1 Source: Company data, BOCOM Int’l estimates Key things to watch We expect Tingyi’s 2Q17 earnings to beat consensus. We anticipate the company to deliver RMB361m net profit in 2Q17, helped by an easy base (RMB76m net profit in 2Q16), Beverage sales momentum revenue reacceleration to 8% (driven by bottled water), and margin expansion (led by Beverage segment profitability expense savings). This implies that Tingyi is likely to produce a 76% YoY net profit growth Instant noodle EBIT margin trend on 6% revenue growth in 1H17. We lift our target P/E on Tingyi to 23.4x (-0.5 SD below its High-margin new product launch LT-average P/E of 26.0x, vs formerly -1SD below), as Tingyi’s value-for-money products have gradually picked up sales momentum.
    [Show full text]
  • Everbright Securities Company Limited
    THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt as to any aspect about this circular or as to the action to be taken, you should consult your stockbroker or other registered dealer in securities, bank manager, solicitor, professional accountant or other professional adviser. If you have sold or transferred all your shares in Everbright Securities Company Limited, you should at once hand this circular, together with the form of proxy and reply slip that have been despatched to you, to the purchaser or transferee or to the bank, stockbroker or other agent through whom the sale or transfer was affected for transmission to the purchaser or transferee. Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this circular, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this circular. Everbright Securities Company Limited 光大證券股份有限公司 (A joint stock company incorporated in the People’s Republic of China with limited liability) (Stock code: 6178) (1) 2019 Report of the Board of Directors (2) 2019 Report of the Supervisory Committee (3) 2019 Annual Report and its summary (4) 2019 Profit Distribution Plan (5) Proposal of Expected Ordinary Related Party/Connected Transactions in 2020 (6) Proposal of Proprietary Trading Businesses Scale in 2020 (7) Proposal of Amendments to the Articles of Association (8) Independent Directors’ Annual Work Report for 2019 (Non-voting matter) and (9) Notice of AGM The 2019 Annual General Meeting (“AGM”) of Everbright Securities Company Limited (the “Company”) will be held at 2:30 p.m.
    [Show full text]